Skip to main content
Have a personal or library account? Click to login
Decisions, Decisions: The Neurobiology of the effects of Dopamine Replacement Therapy on Decision-Making in Parkinson’s Disease Cover

Decisions, Decisions: The Neurobiology of the effects of Dopamine Replacement Therapy on Decision-Making in Parkinson’s Disease

By:   
Open Access
|May 2015

References

  1. Aarts E. Nusselein A. A. Smittenaar P. Helmich R. C. Bloem B. R. Cools R. Greater striatal responses to medication in Parkinson’s disease are associated with better task-switching but worse reward performance Neuropsychologia 2014 62 390 397 10.1016/j.neuropsychologia.2014.05.023
  2. Antonelli F. Ray N. Strafella A. P. Impulsivity and Parkinson‘s disease: More than just disinhibition Journal of the neurological sciences 2011 310 1 202 207 10.1016/j.jns.2011.06.006
  3. Bechara A. Damasio H. Tranel D. Damasio A. R. Deciding advantageously before knowing the advantageous strategy Science 1997 275 5304 1293 1295 10.1126/science.275.5304.1293
  4. Bódi N. Kéri S. Nagy H. Moustafa A. Myers C. E. Daw N. Gluck M. A. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients Brain 2009 1 11 10.1093/brain/awp094
  5. Boller J. K. Barbe M. T. Pauls K. A. M. Reck C. Brand M. Maier F. Kalbe E. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson’s disease Experimental neurology 2014 254 70 77 10.1016/j.expneurol.2014.01.005
  6. Brand M. Labudda K. Kalbe E. Hilker R. Emmans D. Fuchs G. Markowitsch H. J. Decision-making impairments in patients with Parkinson’s disease Behavioural neurology 2004 15 3–4 77 85 10.1155/2004/578354
  7. Brand M. Labudda K. Markowitsch H. J. Neuropsychological correlates of decision-making in ambiguous and risky situations Neural Networks 2006 19 8 1266 1276 10.1016/j.neunet.2006.03.001
  8. Brand M. Recknor E. C. Grabenhorst F. Bechara A. Decisions under ambiguity and decisions under risk: correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules Journal of Clinical and Experimental Neuropsychology 2007 29 1 86 99 10.1080/13803390500507196
  9. Claassen D. O. van den Wildenberg W. P. Ridderinkhof K. R. Jessup C. K. Harrison M. B. Wooten G. F. Wylie S. A. The risky business of dopamine agonists in Parkinson disease and impulse control disorders Behavioral neuroscience 2011 125 4 492 10.1037/a0023795
  10. Claassen D. O. Wylie S. A. Trends and Issues in Characterizing Early Cognitive Changes in Parkinson’s Disease Current neurology and neuroscience reports 2012 12 6 695 702 10.1007/s11910-012-0312-5
  11. Clark L. Bechara A. Damasio H. Aitken M. R. F. Sahakian B. J. Robbins T. W. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making Brain 2008 131 5 1311 1322 10.1093/brain/awn066
  12. Clark C. A. Dagher A. The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling Frontiers in Behavioral Neuroscience 2014 8 10.3389/fnbeh.2014.00196
  13. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease Neuroscience & Biobehavioral Reviews 2006 30 1 1 23 10.1016/j.neubiorev.2005.03.024
  14. Cools R. Barker R. A. Sahakian B. J. Robbins T. W. Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands Cerebral Cortex 2001 11 12 1136 1143 10.1093/cercor/11.12.1136
  15. Cools R. Barker R. A. Sahakian B. J. Robbins T. W. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease Neuropsychologia 2003 41 11 1431 1441 10.1016/S0028-3932(03)00117-9
  16. Czernecki V. Pillon B. Houeto J. L. Pochon J. B. Levy R. Dubois B. Motivation, reward, and Parkinson’s disease: influence of dopatherapy Neuropsychologia 2002 40 13 2257 2267 10.1016/S0028-3932(02)00108-2
  17. De la Fuente-Fernández R. Ruth T. J. Sossi V. Schulzer M. Calne D. B. Stoessl A. J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease Science 2001 293 5532 1164 1166 10.1126/science.1060937
  18. Delazer M. Sinz H. Zamarian L. Stockner H. Seppi K. Wenning G. K. Poewe W. Decision making under risk and under ambiguity in Parkinson’s disease Neuropsychologia 2009 47 8 1901 1908 10.1016/j.neuropsychologia.2009.02.034
  19. Dodd M. L. Klos K. J. Bower J. H. Geda Y. E. Josephs K. A. Ahlskog J. E. Pathological gambling caused by drugs used to treat Parkinson disease Archives of neurology 2005 62 9 1377 1381 10.1001/archneur.62.9.noc50009
  20. Euteneuer F. Schaefer F. Stuermer R. Boucsein W. Timmermann L. Barbe M. T. Kalbe E. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson’s disease: a neuropsychological and psychophysiological study Neuropsychologia 2009 47 13 2882 2890 10.1016/j.neuropsychologia.2009.06.014
  21. Frank M. J. “Go” and “NoGo”: Learning and the Basal Ganglia Cerebrum 2007 Retrieved from http://www.dana.org/Cerebrum/Default.aspx?id=39393
  22. Frank M. J. Seeberger L. C. O‘reilly R. C. By carrot or by stick: cognitive reinforcement learning in parkinsonism Science 2004 306 5703 1940 1943 10.1126/science.1102941
  23. Gleichgerrcht E. Ibáñez A. Roca M. Torralva T. Manes F. Decision-making cognition in neurodegenerative diseases Nature Reviews Neurology 2010 6 11 611 623 10.1038/nrneurol.2010.148
  24. Gotham A. M. Brown R. G. Marsden C. D. ‘Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa Brain 1988 111 2 299 321 10.1093/brain/111.2.299
  25. Hsu M. Bhatt M. Adolphs R. Tranel D. Camerer C. F. Neural systems responding to degrees of uncertainty in human decision-making Science 2005 310 5754 1680 1683 10.1126/science.1115327
  26. Ibarretxe-Bilbao N. Junque C. Tolosa E. Marti M. J. Valldeoriola F. Bargallo N. Zarei M. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson’s disease European Journal of Neuroscience 2009 30 6 1162 1171 10.1111/j.1460-9568.2009.06892.x
  27. Krain A. L. Wilson A. M. Arbuckle R. Castellanos F. X. Milham M. P. Distinct neural mechanisms of risk and ambiguity: a meta-analysis of decision-making Neuroimage 2006 32 1 477 484 10.1016/j.neuroimage.2006.02.047
  28. Labudda K. Brand M. Mertens M. Ollech I. Markowitsch H. J. Woermann F. G. Decision making under risk condition in patients with Parkinson’s disease: a behavioural and fMRI study Behavioural neurology 2010 23 3 131 143 10.3233/BEN-2010-0277
  29. Li X. Lu Z. L. D’Argembeau A. Ng M. Bechara A. The Iowa gambling task in fMRI images Human brain mapping 2010 31 3 410 423 10.1002/hbm.20875
  30. MacDonald P. A. Monchi O. Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson’s disease: implications for cognitive function Parkinson’s Disease 2011 1 18 10.4061/2011/572743
  31. Mavaddat N. Kirkpatrick P. J. Rogers R. D. Sahakian B. J. Deficits in decision-making in patients with aneurysms of the anterior communicating artery Brain 2000 123 10 2109 2117 10.1093/brain/123.10.2109
  32. O’Callaghan C. Bertoux M. Hornberger M. Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration Journal of Neurology, Neurosurgery & Psychiatry 2014 85 4 371 378 10.1136/jnnp-2012-304558
  33. Osman M. Ryterska A. Karimi K. Tu L. Obeso I. Speekenbrink M. Jahanshahi M. The effects of dopaminergic medication on dynamic decision making in Parkinson’s disease Neuropsychologia 2014 53 157 164 10.1016/j.neuropsychologia.2013.10.024
  34. Osman M. Wilkinson L. Beigi M. Castaneda C. S. Jahanshahi M. Patients with Parkinson’s disease learn to control complex systems via procedural as well as non-procedural learning Neuropsychologia 2008 46 9 2355 2363 10.1016/j.neuropsychologia.2008.03.009
  35. Padoa-Schioppa C. Assad J. A. Neurons in the orbitofrontal cortex encode economic value Nature 2006 441 7090 223 226 10.1038/nature04676
  36. Pessiglione M. Seymour B. Flandin G. Dolan R. J. Frith C. D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans Nature 2006 442 7106 1042 1045 10.1038/nature05051
  37. Poletti M. Bonuccelli U. Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson’s disease: a review Therapeutic advances in psychopharmacology 2013 3 2 101 113 10.1177/2045125312470130
  38. Poletti M. Cavedini P. Bonuccelli U. Iowa gambling task in Parkinson’s disease Journal of clinical and experimental neuropsychology 2011 33 4 395 409 10.1080/13803395.2010.524150
  39. Raja M. Rita Bentivoglio A. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson’s disease and other disorders Current drug safety 2012 7 1 63 75 10.2174/157488612800492726
  40. Rangel A. Camerer C. Montague P. R. A framework for studying the neurobiology of value-based decision making Nature Reviews Neuroscience 2008 9 7 545 556 10.1038/nrn2357
  41. Reiff J. Jost W. H. Drug-induced impulse control disorders in Parkinson’s disease Journal of neurology 2011 258 2 323 327 10.1007/s00415-011-5932-1
  42. Robert G. Drapier D. Verin M. Millet B. Azulay J. P. Blin O. Cognitive impulsivity in Parkinson’s disease patients: assessment and pathophysiology Movement Disorders 2009 24 16 2316 2327 10.1002/mds.22836
  43. Ryterska A. Jahanshahi M. Osman M. What are people with Parkinson’s disease really impaired on when it comes to making decisions? A meta-analysis of the evidence Neuroscience & Biobehavioral Reviews 2013 37 10 2836 2846 10.1016/j.neubiorev.2013.10.005
  44. Schönberg T. Daw N. D. Joel D. O’Doherty J. P. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making The Journal of Neuroscience 2007 27 47 12860 12867 10.1523/JNEUROSCI.2496-07.2007
  45. Schultz W. Predictive reward signal of dopamine neurons Journal of neurophysiology 1998 80 1 1 27
  46. Schultz W. Dayan P. Montague P. R. A neural substrate of prediction and reward Science 1997 275 5306 1593 1599 10.1126/science.275.5306.1593
  47. Seedat S. Kesler S. Niehaus D. J. Stein D. J. Pathological gambling behaviour: emergence secondary to treatment of Parkinson’s disease with dopaminergic agents Depression and anxiety 2000 11 4 185 186 10.1002/1520-6394(2000)11:4<;185::AID-DA8>30.CO;2-H
  48. Shiner T. Seymour B. Wunderlich K. Hill C. Bhatia K. P. Dayan P. Dolan R. J. Dopamine and performance in a reinforcement learning task: evidence from Parkinson’s disease Brain 2012 135 6 1871 1883 10.1093/brain/aws083
  49. Thiel A. Hilker R. Kessler J. Habedank B. Herholz K. Heiss W. D. Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study Journal of neural transmission 2003 110 11 1289 1301 10.1007/s00702-003-0041-7
  50. Torta D. M. Castelli L. Reward pathways in Parkinson’s disease: clinical and theoretical implications Psychiatry and clinical neurosciences 2008 62 2 203 213 10.1111/j.1440-1819.2008.01756.x
  51. Trepel C. Fox C. R. Poldrack R. A. Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk Cognitive Brain Research 2005 23 1 34 50 10.1016/j.cogbrainres.2005.01.016
  52. van Eimeren T. Ballanger B. Pellecchia G. Miyasaki J. M. Lang A. E. Strafella A. P. Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson‘s Disease Neuropsychopharmacology 2009 34 13 2758 2766 10.1038/npp.2009.124
  53. Voon V. Fernagut P. O. Wickens J. Baunez C. Rodriguez M. Pavon N. Bezard E. Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders The Lancet Neurology 2009 8 12 1140 1149 10.1016/S1474-4422(09)70287-X
  54. Voon V. Fox S. H. Medication-related impulse control and repetitive behaviors in Parkinson disease Archives of Neurology 2007 64 8 1089 1096 10.1001/archneur.64.8.1089
  55. Voon V. Pessiglione M. Brezing C. Gallea C. Fernandez H. H. Dolan R. J. Hallett M. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors Neuron 2010 65 1 135 142 10.1016/j.neuron.2009.12.027
  56. Voon V. Potenza M. N. Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson’s disease Current opinion in neurology 2007 20 4 484 492 10.1097/WCO.0b013e32826fbc8f
  57. Weintraub D. Dopamine and impulse control disorders in Parkinson’s disease Annals of neurology 2008 64 S2 S93 S100 10.1002/ana.21454
  58. Weintraub D. Koester J. Potenza M. N. Siderowf A. D. Stacy M. Voon V. Lang A. E. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Archives of neurology 2010 67 5 589 595 10.1001/archneurol.2010.65
  59. Wiecki T. V. Frank M. J. Neurocomputational models of motor and cognitive deficits in Parkinson’s disease Progress in brain research 2010 183 275 297 10.1016/S0079-6123(10)83014-6
  60. Williams G. V. Goldman-Rakic P. S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex Nature 1995 376 572 575 10.1038/376572a0
  61. Witt K. Daniels C. Daniel V. Schmitt-Eliassen J. Volkmann J. Deuschl G. Patients with Parkinson’s disease learn to control complex systems—an indication for intact implicit cognitive skill learning Neuropsychologia 2006 44 12 2445 2451 10.1016/j.neuropsychologia.2006.04.013
  62. Zelazo P. D. Cunningham W. A. Gross J. J. Executive Function: Mechanisms Underlying Emotion Regulation Handbook of emotion regulation 2007 135 158 New York, NY, US Guilford Press
  63. Zgaljardic D. J. Borod J. C. Foldi N. S. Mattis P. A review of the cognitive and behavioral sequelae of Parkinson’s disease: relationship to frontostriatal circuitry Cognitive and behavioral neurology 2003 16 4 193 210 10.1097/00146965-200312000-00001
DOI: https://doi.org/10.5334/jeps.cv | Journal eISSN: 2222-6931
Language: English
Page range: 45 - 52
Published on: May 29, 2015
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2015 Julie Lee, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.